A continuous postoperative sivelestat infusion reduced ARDS rates versus placebo after cardiovascular surgery (16.8% vs 31.2%; P < .001). Ninety-day all-cause mortality was lower with sivelestat ...
On February 24, 2026, Edesa Biotech, Inc. (NASDAQ:EDSA) announced additional Phase 3 results from its paridiprubart (EB05) study in acute respiratory distress syndrome (ARDS) that extend beyond the ...
Orlando (Fla.) Jones four-star edge rusher Frederick Ards III has narrowed his list of more than 40 offers down to five schools, he tells Rivals’ Hayes Fawcett. Ards also has plans to visit the ...
May reduce secondary shock in severe pneumonia, but have little to no effect on hospital-acquired infections. HealthDay News — Adjunct corticosteroids probably reduce short-term mortality in adults ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Objective This systematic review aimed to describe the connection between the inspired oxygen fraction and pulmonary complications in adult patients, with the objective of determining a safe upper ...
Rotating through the R Adams Crowley Shock Trauma Center in Baltimore was a rite of passage for critical care medicine fellows in my training program. Long before my visit, I’d heard about Dr Nader ...
In experiments with ARDS model mice, researchers from Japan found that basophils, a type of white blood cells, release interleukin-4, a signaling molecule that suppresses inflammatory neutrophils ...
Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. An AI-powered algorithm that sifts through data from ...
Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results